[1]Seow YQ, Wood MJ. Biological gene delivery vehicles:beyond viral vectors[J]. Molecular therapy, 2009, 17(5):767-777. [2]郭勇, 曾庆平. 基因治疗药物的研究进展[J]. 药物生物技术, 1996(3):181-186. [3]Marshall E. Gene therapy death prompts review of adenovirus vector. [J]. Science, 1999, 286(5448):2244-2245. [4]Chen ZY, He CY, Meuse L, et al. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo[J]. Gene Therapy, 2004, 11(10):856-864. [5] Pang AS. Production of antibodies against Bacillus thuringiensis delta-endotoxin by injecting its plasmids. [J]. Biochem Biophys Res Commun, 1994, 202(3):1227-1234. [6]Bartlett JS. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors[J]. J Virol, 2000, 74(6):2777-2785. [7]Sanlioglu S. Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation[J]. J Virol, 2000, 74(19):9184-9196. [8]Akache. A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8[J]. Mol Ther, 2007, 15(2):330-339. [9]Zaiss AK. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors[J]. J Virol, 2002, 76(9):4580-4590. [10]Weindler FW, Heilbronn R. A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication[J]. J Virol, 1991, 65(5):2476-2483. [11]Summerford. AlphaVbeta5 integrin:a co-receptor for adeno-associated virus type 2 infection[J]. Nat Med, 1999, 5(1):78-82. [12]Qing K. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2[J]. Nat Med, 1999, 5(1):71-77. [13]Bakowska JC, Di Maria MV, Camp SM, et al. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+)hybrid amplicon vector[J]. Gene Ther, 2003, 10(19):1691-1702. [14]Huttner NA, Girod A, Schnittqer S, et al. Analysis of site-specific transgene integration following cotransduction with recombinant adeno-associated virus and a rep encodingplasmid[J]. J Gene Med, 2003, 5(2):120-129. [15]Manno CS. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B[J]. Blood, 2003, 101(8):2963-2972. [16]Maguire AM, High KA, Auricchio A, et al. Safety and efficacy of gene transfer for Leber’s congenital amaurosis[J]. N Engl J Med, 2008, 358(21):2240-2248. [17]李泰明, 潘俊杰, 祁静, 等. 昆虫细胞制备 AAV-ITR 基因表达微载体[J]. 生物工程学报, DOI:10. 13345/j. cjb. 140485. [18]Alberts B. The breakthroughs of 2009. [J]. Science, 2009, 326(5960):1589. [19]Yla-Herttuala S. Endgame:glybera finally recommended for approval as the first gene therapy drug in the European union[J]. Mol Ther, 2012, 20(10):1831-1832. [20]Miller N. Glybera and the future of gene therapy in the European Union[J]. Nat Rev Drug Discov, 2012, 11(5):419. [21] Henckaerts E, Linden RM. Adeno-associated virus:a key to the human genome? [J]. Future Virol, 2010, 5(5):555-574. [22] Coura Rdos S, Nardi NB, The state of the art of adeno-associated virus-based vectors in gene therapy[J]. Virol J, 2007, 4:99. [23] Grieger JC, Samulski RJ. Adeno-associated virus as a gene therapy vector:vector development, production and clinical applications[J]. Adv Biochem Eng Biotechnol, 2005, 99:119-145. [24] Kobelt D, Schleef M, Schmeer M, et al. Performance of high quality minicircle DNA for in vitro and in vivo gene transfer[J]. Mol Biotechnol, 2013, 53(1):80-89. [25] Mayrhofer P, Iro M. Gene Vaccines[M]. Thalhamer J, Weiss R, Scheiblhofer S, Editors. Springer Vienna, 2012:297-310. [26] Maniar LEG, Maniar JM, Chen ZY, et al. Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level[J]. Mol Ther, 2013, 21(1):131-138. [27] Mayrhofer P, Schleef M, Jechlinger W. Gene Therapy of Cancer[M]. Methods in Molecular BiologyTM, 2009:87-104. [28] Duan D, Yan Z, Yue Y, et al. Structural analysis of adeno-associated virus transduction circular intermediates[J]. Virology, 1999, 261(1):8-14. [29]Cervelli T, Backovic A, Galli A. Formation of AAV single stranded DNA genome from a circular plasmid in Saccharomyces cerevisiae[J]. PLoS One, 2011, 6(8):e23474. [30]Li L, Dimitriadis EK, Yang Y, et al. Production and characterization of novel recombinant adeno-associated virus replicative-form genomes:a eukaryotic source of DNA for gene transfer[J]. PLoS One, 2013, 8(8):e69879.
|